SUMMARY 5-fluoro-2'-deoxyuridine (FUdR) was found to be highly effective in inducing the heritable fragile site on Xq28 associated with mental retardation. Lymphocytes from two affected males manifested the fragile site in 30 to 40 % of the mitoses when grown in the presence of FUdR.
The expression of the fragile site on the X chromosome (Xq27 or 28, hereafter called Xq28),1 associated with one type of X linked mental retardation,2-14 has been shown to be highly dependent on the culturing conditions.15 16 Apart from a slightly alkaline pH optimum and a low serum content (5 %Y), the main factor necessary for the expression of the fragile site on the X is the culture medium's deficiency of folic acid and thymidine. The fragile site is expressed in medium 199 which is relatively deficient in folic acid (O 1 mg/i), whereas in McCoy's medium, which is rich in folic acid (10 mg/i), no fragile site can be seen. Also, the folic acid antagonist methotrexate (MTX) enhances the expression.
The nature of the above mentioned inducers and inhibitors suggests that the process of expression could be operating during DNA synthesis, as discussed by Sutherland,16 the critical step being the conversion of uridine monophosphate (dUMP) to thymidine monophosphate (dTMP) catalysed by the enzyme thymidylate synthetase. This reaction requires as co-enzyme the folic acid derivative 5,10- methylene tetrahydrofolate (CH2 = FAH4) which is converted to dihydrofolate (FAH2) (fig 1) .
Accordingly the known inducers of the fragile site, folic acid deficiency and MTX, will limit the amount of CH2 = FAH4, thereby limiting the pool of dTMP required for DNA synthesis, whereas the known inhibitors, folic acid and thymidine, will increase the pool of dTMP available for incorporation into DNA.
Received for publication 22 In preliminary experiments we have tested whether 5-fluoro-2'-deoxyuridine (FUdR) could mimic the effect of folic acid deficiency on the expression of the fragile site on the X chromosome. The rationale is that FUdR in mammalian cells is converted to fluoro-deoxyuridine monophosphate (dFUMP), which is a strong and specific inhibitor of thymidylate synthetase (fig 1) .17 18 374 S-fluoro-2'-deoxyuridine induction of the fragile site on Xq28 We found no morphological differences between the appearance of the fragile sites induced by either folic acid deficiency or FUdR (fig 2) . Apart from the fragile site on the X chromosome, other nonrandomly situated gaps and breaks were frequently observed in the FUdR treated cultures. This was also the case when cells were cultured in folic acid deficient medium (unpublished results).
Discussion
It is interesting to note that in the folic acid deficient medium 199 the addition of FUdR did not increase the frequency of cells expressing the fragile site, whereas in the folic acid rich medium (McCoy's) the effect of FUdR was evident. One possible explanation for this is that in the presence of CH2 = FAH4 a marked enhancement of the binding of dFUMP to thymidylate synthetase occurs.18 In practical terms this could mean that in order to get the optimal inhibiting activity of FUdR the medium should be rich in folic acid. This could simplify the detection of fragile sites considerably, since most chromosomal culturing media have a higher folic acid content than medium 199.
In this preliminary observation we have not defined the optimal concentration or culturing conditions for the FUdR induced fragile site on Xq28. It may well be that the optimal condition varies between subjects and between different cell types, in view of the great variability in the expression of this fragile site reported by all investigators. In particular, severe difficulties are associated with the detection of the fragile site in female carriers ( 
